Related Experiment Videos

A robust method for detecting CHK2/RAD53 mutations in genomic DNA

Nayanta Sodha1, Richard S Houlston, Richard Williams

  • 1Royal Marsden NHS Trust, Surrey, UK. nayanta@icr.ac.uk

Human Mutation
|January 17, 2002
PubMed

Insights

Screening for CHK2 mutations can be error-prone due to homologous sequences. A new long-range PCR method accurately analyzes the functional CHK2 gene copy for comprehensive mutation detection.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Germline mutations in CHK2 (Checkpoint Kinase 2) are associated with various cancers.
  • Standard screening methods for CHK2 mutations, such as heteroduplex CSGE and PCR, can be unreliable.
  • Homologous regions in the genome can interfere with accurate mutation detection.

Purpose of the Study:

  • To identify the cause of spurious PCR fragments during CHK2 mutation screening.
  • To develop a reliable method for comprehensive mutational analysis of the functional CHK2 gene.

Main Methods:

  • Heteroduplex CSGE and direct sequencing were used to analyze PCR fragments.
  • Public sequence databases were searched for homologous regions to CHK2 exons.
  • A novel strategy employing long-range PCR was developed to specifically amplify the functional CHK2 gene.

Main Results:

  • Additional PCR fragments were generated from the 3' end of CHK2 (exons 11-14), indicating amplification of homologous loci.
  • High homology was found between CHK2 exons 10-14 and other genomic regions.
  • The developed long-range PCR method successfully screened the functional CHK2 copy, circumventing amplification errors.

Conclusions:

  • Standard PCR-based screening methods for CHK2 mutations are prone to errors due to pseudogene amplification.
  • Long-range PCR provides a robust strategy for accurate and comprehensive mutational analysis of the functional CHK2 gene.
  • This improved methodology is crucial for reliable genetic screening in cancer diagnostics.

Related Concept Videos